Literature DB >> 22271279

Plasma RANTES and eotaxin levels are correlated with the severity of chronic rhinosinusitis.

Pin-Zhir Chao1, Chi-Ming Chou, Chen-Ho Chen.   

Abstract

Eosinophilia occurs in up to 75-90% of nasal polyps in Caucasians. The chemokines eotaxin and RANTES increase eosinophil recruitment, activation, and survival, and these chemokines are significantly expressed in nasal polyps. We hypothesized that eotaxin and RANTES plasma levels might be correlated with disease severity. We compared the eotaxin and RANTES plasma levels in 20 Taiwanese patients with chronic rhinosinusitis and nasal polyps and 20 Taiwanese healthy controls. Eotaxin and RANTES plasma levels were measured by ELISA and disease severity was scored by CT scans. Compared to controls, patients with nasal polyps had significantly elevated plasma levels of eotaxin and RANTES and increased peripheral blood eosinophils (p < 0.001). Eotaxin plasma levels were significantly correlated with disease severity in patients with chronic rhinosinusitis to a greater extent than were RANTES levels. RANTES and eotaxin levels were also positively correlated with the percentages of peripheral blood eosinophils. Eotaxin plasma levels are significantly correlated with disease severity in Taiwanese patients with nasal polyposis to a greater degree than are RANTES levels. Additional studies are needed to assess whether eotaxin plasma levels can be used to monitor disease progression and attenuation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22271279     DOI: 10.1007/s00405-012-1927-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  29 in total

Review 1.  An immunological approach to chronic and recurrent sinusitis.

Authors:  Marshall T Wise; David D Hagaman
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2007-02       Impact factor: 2.064

2.  Interleukin 5, IL6, IL12, IFN-gamma, RANTES and Fractalkine in human nasal polyps, turbinate mucosa and serum.

Authors:  Arild Danielsen; Turid Tynning; Karl A Brokstad; Jan Olofsson; Ake Davidsson
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-02-03       Impact factor: 2.503

Review 3.  Nasal polyposis: an update: editorial review.

Authors:  Ruby Pawankar
Journal:  Curr Opin Allergy Clin Immunol       Date:  2003-02

Review 4.  Innate immunity of the sinonasal cavity and its role in chronic rhinosinusitis.

Authors:  Murugappan Ramanathan; Andrew P Lane
Journal:  Otolaryngol Head Neck Surg       Date:  2007-03       Impact factor: 3.497

5.  Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils.

Authors:  S H Shin; J Y Park; C H Jeon; J K Choi; S H Lee
Journal:  Laryngoscope       Date:  2000-08       Impact factor: 3.325

6.  IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration.

Authors:  Kousuke Yoshifuku; Shoji Matsune; Junichiro Ohori; Yukari Sagara; Tatsuya Fukuiwa; Yuichi Kurono
Journal:  Rhinology       Date:  2007-09       Impact factor: 3.681

7.  Morpho-functional evaluation of osteomeatal complex in chronic sinusitis by coronal CT.

Authors:  Xavier Pruna
Journal:  Eur Radiol       Date:  2002-10-02       Impact factor: 5.315

Review 8.  Chronic sinusitis: symptoms versus CT scan findings.

Authors:  Michael G Stewart; Romaine F Johnson
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2004-02       Impact factor: 2.064

9.  Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia.

Authors:  L J Newman; T A Platts-Mills; C D Phillips; K C Hazen; C W Gross
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

10.  GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP).

Authors:  D L Hamilos; D Y Leung; D P Huston; A Kamil; R Wood; Q Hamid
Journal:  Clin Exp Allergy       Date:  1998-09       Impact factor: 5.018

View more
  6 in total

Review 1.  Clinical and biological markers of difficult-to-treat severe chronic rhinosinusitis.

Authors:  Mauricio López-Chacón; Joaquim Mullol; Laura Pujols
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

2.  Eosinophil Chemokines and Clara Cell Protein 16 Production in Nasal Mucosa of Patients with Persistent Allergic Rhinitis.

Authors:  Aleksandar Perić; Cveta Špadijer Mirković; Biserka Vukomanović Đurđević; Aneta V Perić; Danilo Vojvodić
Journal:  Eurasian J Med       Date:  2017-10

3.  A family-based genome-wide association study of chronic rhinosinusitis with nasal polyps implicates several genes in the disease pathogenesis.

Authors:  Anton Bohman; Julius Juodakis; Martin Oscarsson; Jonas Bacelis; Mats Bende; Åsa Torinsson Naluai
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

4.  Cytokine patterns in nasal secretion of non-atopic patients distinguish between chronic rhinosinusitis with or without nasal polys.

Authors:  Katrin König; Christine Klemens; Mareike Haack; Marion San Nicoló; Sven Becker; Matthias F Kramer; Moritz Gröger
Journal:  Allergy Asthma Clin Immunol       Date:  2016-04-27       Impact factor: 3.406

5.  The "Aging Factor" Eotaxin-1 (CCL11) Is Detectable in Transfusion Blood Products and Increases with the Donor's Age.

Authors:  Julia Hoefer; Markus Luger; Christian Dal-Pont; Zoran Culig; Harald Schennach; Stefan Jochberger
Journal:  Front Aging Neurosci       Date:  2017-12-01       Impact factor: 5.750

6.  Elevated S100A9 expression in chronic rhinosinusitis coincides with elevated MMP production and proliferation in vitro.

Authors:  Marina Boruk; Christopher Railwah; Alnardo Lora; Sridesh Nath; Derek Wu; Lillian Chow; Panid Borhanjoo; Abdoulaye J Dabo; Sadakat Chowdhury; Ryan Kaiser; Robert F Foronjy; Richard Rosenfeld; Patrick Geraghty
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.